{"rows":[{"id":5676,"title":"Psilocybin therapy for adult females with anorexia nervosa: pilot study","authors":"Douglass Hannah M., Spriggs Meg J., Godfrey Kate, Danby Jennifer L., de Magalhaes Frederico J. C., Macdonald Lauren, Alderton Kirsty L., Archer Stephanie, Ahmad Kirran, Martell Jonny, Frias Jennifer T., Sawicka Gabriela, Read Tim, Blemings Allan, Lafrance Adele, Nicholls Dasha, Erritzoe David, Park Rebecca J., Nutt David J., Carhart-Harris Robin L.","journal":"The British Journal of Psychiatry","publication_date":"2026-07-08","publication_year":2026,"doi":"10.1192/bjp.2026.10687","pubmed_id":"42414058","openalex_id":"https://openalex.org/W7167587921","source_url":"https://doi.org/10.1192/bjp.2026.10687","substance_tags":"psilocybin","topic_tags":"Eating Disorders,Headache / Migraine,Clinical Trial,Safety,Adverse Events","study_type":"Clinical Trial","source_name":"Crossref","publication_status":"published","date_added":"2026-07-08 01:20:22","last_checked":"2026-08-09 08:28:46","bibtex":null,"source_record_id":"PMID:42414058","abstract_available":true,"abstract_source":"Crossref","abstract_source_url":"https://doi.org/10.1192/bjp.2026.10687","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Crossref","source_record_id":"PMID:42414058","source_url":"https://doi.org/10.1192/bjp.2026.10687","doi":"10.1192/bjp.2026.10687","pmid":"42414058","publication_date":"2026-07-08","importer_version":"2.1.3","text_redistributed":false}},{"id":5333,"title":"P.1.e.017 The functional brain correlates of the psychedelic state: an arterial spin labelling study with psilocybin","authors":"Robin Carhart-Harris, David Erritzøe, James Stone, Rjs Wise, David Nutt","journal":"European Neuropsychopharmacology","publication_date":"2011-08-07","publication_year":2011,"doi":"10.1016/s0924-977x(11)70495-3","pubmed_id":null,"openalex_id":"https://openalex.org/W2061147949","source_url":"https://doi.org/10.1016/s0924-977x(11)70495-3","substance_tags":"psilocybin","topic_tags":"Mechanism of Action,Cancer Patients","study_type":"Other","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:52:05","last_checked":"2026-08-09 08:25:54","bibtex":null,"source_record_id":"DOI:10.1016/s0924-977x(11)70495-3","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/s0924-977x(11)70495-3","source_url":"https://doi.org/10.1016/s0924-977x(11)70495-3","doi":"10.1016/s0924-977x(11)70495-3","pmid":"","publication_date":"2011-08-07","importer_version":"2.1.3","text_redistributed":false}},{"id":5049,"title":"Psychedelic experience dose-dependently modulated by cannabis: results of a prospective online survey","authors":"Joanna Kuc, Hannes Kettner, Fernando E. Rosas, David Erritzøe, Eline Haijen, Mendel Kaelen, David Nutt, Robin Carhart-Harris","journal":"Psychopharmacology","publication_date":"2021-11-03","publication_year":2021,"doi":"10.1007/s00213-021-05999-1","pubmed_id":"34734314","openalex_id":"https://openalex.org/W3208662682","source_url":"https://doi.org/10.1007/s00213-021-05999-1","substance_tags":"psilocybin","topic_tags":"Chronic Pain,Consciousness,Emotional Processing,Mystical Experience,Observational Study,Toxicity,Drug Interactions","study_type":"Observational Study","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:51:58","last_checked":"2026-07-04 06:51:58","bibtex":null,"source_record_id":"PMID:34734314","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.1007/s00213-021-05999-1","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"PMID:34734314","source_url":"https://doi.org/10.1007/s00213-021-05999-1","doi":"10.1007/s00213-021-05999-1","pmid":"34734314","publication_date":"2021-11-03","importer_version":"2.1.3","text_redistributed":false}},{"id":5038,"title":"P.0353 Study protocol: psilocybin as a treatment for anorexia nervosa: a pilot study","authors":"Hannah Douglass, Meg J. Spriggs, R.J. Park, Tim Read, Jennifer L. Danby, Frederico José Coelho de Magalhães, Kirsty L. Alderton, Adèle Lafrance, Dasha Nicholls, David Erritzøe, David Nutt, Robin Carhart-Harris","journal":"European Neuropsychopharmacology","publication_date":"2021-12-01","publication_year":2021,"doi":"10.1016/j.euroneuro.2021.10.335","pubmed_id":null,"openalex_id":"https://openalex.org/W4200393290","source_url":"https://doi.org/10.1016/j.euroneuro.2021.10.335","substance_tags":"psilocybin","topic_tags":"Eating Disorders,Receptor Pharmacology","study_type":"Other","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:51:58","last_checked":"2026-08-09 08:25:44","bibtex":null,"source_record_id":"DOI:10.1016/j.euroneuro.2021.10.335","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.euroneuro.2021.10.335","source_url":"https://doi.org/10.1016/j.euroneuro.2021.10.335","doi":"10.1016/j.euroneuro.2021.10.335","pmid":"","publication_date":"2021-12-01","importer_version":"2.1.3","text_redistributed":false}},{"id":5036,"title":"P.0828 Psilocybin enhances emotional response to music in healthy individuals","authors":"Dea Siggaard Stenbæk, M. Madsen, Sophia Armand, Catharina Messel, Maria Zofia Grzywacz, David Erritzøe, Gitte M. Knudsen, Patrick M. Fisher","journal":"European Neuropsychopharmacology","publication_date":"2021-12-01","publication_year":2021,"doi":"10.1016/j.euroneuro.2021.10.687","pubmed_id":null,"openalex_id":"https://openalex.org/W4200119156","source_url":"https://doi.org/10.1016/j.euroneuro.2021.10.687","substance_tags":"psilocybin","topic_tags":"Emotional Processing","study_type":"Other","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:51:58","last_checked":"2026-08-09 08:25:44","bibtex":null,"source_record_id":"DOI:10.1016/j.euroneuro.2021.10.687","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.euroneuro.2021.10.687","source_url":"https://doi.org/10.1016/j.euroneuro.2021.10.687","doi":"10.1016/j.euroneuro.2021.10.687","pmid":"","publication_date":"2021-12-01","importer_version":"2.1.3","text_redistributed":false}},{"id":4866,"title":"Psilocybin as a treatment for anorexia nervosa: 6-week and 3-month follow-up results","authors":"Hannah Douglass, Merle Spriggs, Kate Godfrey, Jennifer L. Danby, Francisco Magalhães, Kirsty L. Alderton, Liane Macdonald, Stephanie Archer, Tim Read, Adèle Lafrance, Dasha Nicholls, David Erritzøe, R. Park, David Nutt, Robin Carhart-Harris","journal":"Neuroscience Applied","publication_date":"2023-01-01","publication_year":2023,"doi":"10.1016/j.nsa.2023.102878","pubmed_id":null,"openalex_id":"https://openalex.org/W4390223843","source_url":"http://dx.doi.org/10.1016/j.nsa.2023.102878","substance_tags":"psilocybin","topic_tags":"Eating Disorders","study_type":"Other","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:34:46","last_checked":"2026-08-09 08:25:38","bibtex":null,"source_record_id":"DOI:10.1016/j.nsa.2023.102878","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.nsa.2023.102878","source_url":"http://dx.doi.org/10.1016/j.nsa.2023.102878","doi":"10.1016/j.nsa.2023.102878","pmid":"","publication_date":"2023-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":4712,"title":"Psilocybin vs Escitalopram for depression: 6-month follow-up","authors":"Thomas Barba, David Erritzøe, Kyle T. Greenway, Rinki Murphy, John Martell, Christopher Timmermann, Ashleigh Murphy-Beiner, Bruna Giribaldi, Michelle Baker Jones, Brandon Weiss, Robin Carhart-Harris","journal":"Neuroscience Applied","publication_date":"2024-01-01","publication_year":2024,"doi":"10.1016/j.nsa.2024.104377","pubmed_id":null,"openalex_id":"https://openalex.org/W4405637013","source_url":"https://doi.org/10.1016/j.nsa.2024.104377","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety","study_type":"Other","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:34:44","last_checked":"2026-08-09 08:25:32","bibtex":null,"source_record_id":"DOI:10.1016/j.nsa.2024.104377","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.nsa.2024.104377","source_url":"https://doi.org/10.1016/j.nsa.2024.104377","doi":"10.1016/j.nsa.2024.104377","pmid":"","publication_date":"2024-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":4667,"title":"Unique Psychological Mechanisms Underlying Psilocybin Therapy Versus Escitalopram Treatment in the Treatment of Major Depressive Disorder","authors":"Brandon Weiss, Leor Roseman, Bruna Giribaldi, David Nutt, Robin Carhart-Harris, David Erritzøe","journal":"International Journal of Mental Health and Addiction","publication_date":"2024-03-07","publication_year":2024,"doi":"10.1007/s11469-024-01253-9","pubmed_id":null,"openalex_id":"https://openalex.org/W4392550813","source_url":"https://doi.org/10.1007/s11469-024-01253-9","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,Mechanism of Action,Receptor Pharmacology,Emotional Processing,Mystical Experience,Clinical Trial,Treatment-Resistant Depression","study_type":"Clinical Trial","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:34:43","last_checked":"2026-08-09 08:25:30","bibtex":null,"source_record_id":"DOI:10.1007/s11469-024-01253-9","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.1007/s11469-024-01253-9","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1007/s11469-024-01253-9","source_url":"https://doi.org/10.1007/s11469-024-01253-9","doi":"10.1007/s11469-024-01253-9","pmid":"","publication_date":"2024-03-07","importer_version":"2.1.3","text_redistributed":false}},{"id":4475,"title":"Effects of escitalopram and psilocybin therapy on mesolimbic resting-state functional connectivity in depression","authors":"Rebecca Harding, Natalie Ertl, Rabia Zafar, Magnus Wall, Rajkanya Das, David Erritzøe, David Nutt, Robin Carhart-Harris","journal":"Neuroscience Applied","publication_date":"2025-01-01","publication_year":2025,"doi":"10.1016/j.nsa.2025.105421","pubmed_id":null,"openalex_id":"https://openalex.org/W4408526135","source_url":"https://doi.org/10.1016/j.nsa.2025.105421","substance_tags":"psilocybin","topic_tags":"Depression,Brain Imaging","study_type":"Other","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:34:41","last_checked":"2026-08-09 08:25:24","bibtex":null,"source_record_id":"DOI:10.1016/j.nsa.2025.105421","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.nsa.2025.105421","source_url":"https://doi.org/10.1016/j.nsa.2025.105421","doi":"10.1016/j.nsa.2025.105421","pmid":"","publication_date":"2025-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":4303,"title":"A lexicon for psychedelic research and treatment","authors":"David Nutt, David Erritzøe, Anne Katrin Schlag, David Luke, Deborah C. Mash, Hiroyuki Uchida, Jacob S. Aday, James Rucker, Liliana Galindo, Mark Sweeney, Matthew X. Lowe, Oliver Davis, Plinio Ferreira, Rayyan Zafar, Robin Carhart-Harris, Tadeusz Hawrot, Joanna C. Neill","journal":"Drug Science Policy and Law","publication_date":"2025-08-31","publication_year":2025,"doi":"10.1177/20503245251380511","pubmed_id":null,"openalex_id":"https://openalex.org/W4414407628","source_url":"https://doi.org/10.1177/20503245251380511","substance_tags":"psilocybin","topic_tags":"Depression,Pharmacology,Microdosing,Clinical Trial,Treatment-Resistant Depression,Safety","study_type":"Clinical Trial","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:34:39","last_checked":"2026-07-04 07:00:33","bibtex":null,"source_record_id":"DOI:10.1177/20503245251380511","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.1177/20503245251380511","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1177/20503245251380511","source_url":"https://doi.org/10.1177/20503245251380511","doi":"10.1177/20503245251380511","pmid":"","publication_date":"2025-08-31","importer_version":"2.1.3","text_redistributed":false}},{"id":3904,"title":"P.839 Modelling the acute temporal dynamics of psilocybin psychoactive effects; relation to brain serotonin 2a receptor levels","authors":"Dea Siggaard Stenbæk, M.K. Madsen, Brice Ozenne, Søren Kristiansen, Daniel Burmester, David Erritzøe, Gitte M. Knudsen, Patrick M. Fisher","journal":"European Neuropsychopharmacology","publication_date":"2019-12-01","publication_year":2019,"doi":"10.1016/j.euroneuro.2019.09.702","pubmed_id":null,"openalex_id":"https://openalex.org/W4231945730","source_url":"https://doi.org/10.1016/j.euroneuro.2019.09.702","substance_tags":"psilocybin","topic_tags":"Pharmacology,Receptor Pharmacology","study_type":"Other","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-02 20:42:13","last_checked":"2026-08-09 08:25:49","bibtex":null,"source_record_id":"DOI:10.1016/j.euroneuro.2019.09.702","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.euroneuro.2019.09.702","source_url":"https://doi.org/10.1016/j.euroneuro.2019.09.702","doi":"10.1016/j.euroneuro.2019.09.702","pmid":"","publication_date":"2019-12-01","importer_version":"2.1.3","text_redistributed":false}},{"id":3730,"title":"A Bayesian Reanalysis of a Trial of Psilocybin versus Escitalopram for Depression.","authors":"Nayak SM, Bari BA, Yaden DB, Spriggs MJ, Rosas FE, Peill JM, Giribaldi B, Erritzoe D, Nutt DJ, Carhart-Harris R","journal":"Psychedelic medicine (New Rochelle, N.Y.)","publication_date":"2023-03-01","publication_year":2023,"doi":"10.1089/psymed.2022.0002","pubmed_id":"37337526","openalex_id":"https://openalex.org/W4307481727","source_url":"https://pubmed.ncbi.nlm.nih.gov/37337526/","substance_tags":"psilocybin","topic_tags":"Depression","study_type":"Other","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 11:08:42","last_checked":"2026-08-09 08:28:17","bibtex":null,"source_record_id":"PMID:37337526","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/37337526/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:37337526","source_url":"https://pubmed.ncbi.nlm.nih.gov/37337526/","doi":"10.1089/psymed.2022.0002","pmid":"37337526","publication_date":"2023-03-01","importer_version":"2.1.3","text_redistributed":false}},{"id":3728,"title":"Neuroimaging in psychedelic drug development: past, present, and future.","authors":"Wall MB, Harding R, Zafar R, Rabiner EA, Nutt DJ, Erritzoe D","journal":"Molecular psychiatry","publication_date":"2023-09-01","publication_year":2023,"doi":"10.1038/s41380-023-02271-0","pubmed_id":"37759038","openalex_id":"https://openalex.org/W4387105816","source_url":"https://pubmed.ncbi.nlm.nih.gov/37759038/","substance_tags":"psilocybin","topic_tags":"Depression,PTSD,Addiction,Neuroplasticity,Brain Imaging,Pharmacology,Receptor Pharmacology,Aging","study_type":"Clinical Trial","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 11:08:42","last_checked":"2026-08-09 08:28:13","bibtex":null,"source_record_id":"PMID:37759038","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/37759038/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:37759038","source_url":"https://pubmed.ncbi.nlm.nih.gov/37759038/","doi":"10.1038/s41380-023-02271-0","pmid":"37759038","publication_date":"2023-09-01","importer_version":"2.1.3","text_redistributed":false}},{"id":2608,"title":"Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin.","authors":"Carhart-Harris RL, Erritzoe D, Williams T, Stone JM, Reed LJ, Colasanti A, Tyacke RJ, Leech R, Malizia AL, Murphy K, Hobden P, Evans J, Feilding A, Wise RG, Nutt DJ","journal":"Proceedings of the National Academy of Sciences of the United States of America","publication_date":"2012-02-07","publication_year":2012,"doi":"10.1073/pnas.1119598109","pubmed_id":"22308440","openalex_id":"https://openalex.org/W2026832357","source_url":"https://pubmed.ncbi.nlm.nih.gov/22308440/","substance_tags":"psilocybin","topic_tags":"Brain Imaging,Consciousness,Healthy Volunteers,Drug Interactions","study_type":"Other","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:54:14","last_checked":"2026-08-09 08:28:28","bibtex":null,"source_record_id":"PMID:22308440","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/22308440/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:22308440","source_url":"https://pubmed.ncbi.nlm.nih.gov/22308440/","doi":"10.1073/pnas.1119598109","pmid":"22308440","publication_date":"2012-02-07","importer_version":"2.1.3","text_redistributed":false}},{"id":2606,"title":"Implications for psychedelic-assisted psychotherapy: functional magnetic resonance imaging study with psilocybin.","authors":"Carhart-Harris RL, Leech R, Williams TM, Erritzoe D, Abbasi N, Bargiotas T, Hobden P, Sharp DJ, Evans J, Feilding A, Wise RG, Nutt DJ","journal":"The British journal of psychiatry: the journal of mental science","publication_date":"2012-03-01","publication_year":2012,"doi":"10.1192/bjp.bp.111.103309","pubmed_id":"22282432","openalex_id":"https://openalex.org/W2119134849","source_url":"https://pubmed.ncbi.nlm.nih.gov/22282432/","substance_tags":"psilocybin","topic_tags":"Brain Imaging,Aging,Emotional Processing,Clinical Trial,Healthy Volunteers","study_type":"Clinical Trial","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:54:14","last_checked":"2026-08-09 08:28:28","bibtex":null,"source_record_id":"PMID:22282432","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/22282432/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:22282432","source_url":"https://pubmed.ncbi.nlm.nih.gov/22282432/","doi":"10.1192/bjp.bp.111.103309","pmid":"22282432","publication_date":"2012-03-01","importer_version":"2.1.3","text_redistributed":false}},{"id":2603,"title":"Simultaneous polysubstance use among Danish 3,4-methylenedioxymethamphetamine and hallucinogen users: combination patterns and proposed biological bases.","authors":"Licht CL, Christoffersen M, Okholm M, Damgaard L, Fink-Jensen A, Knudsen GM, Erritzoe D","journal":"Human psychopharmacology","publication_date":"2012-07-01","publication_year":2012,"doi":"10.1002/hup.2234","pubmed_id":"22696164","openalex_id":"https://openalex.org/W1948675593","source_url":"https://pubmed.ncbi.nlm.nih.gov/22696164/","substance_tags":"psilocybin","topic_tags":"Addiction,Observational Study","study_type":"Observational Study","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:54:14","last_checked":"2026-08-09 08:28:28","bibtex":null,"source_record_id":"PMID:22696164","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/22696164/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:22696164","source_url":"https://pubmed.ncbi.nlm.nih.gov/22696164/","doi":"10.1002/hup.2234","pmid":"22696164","publication_date":"2012-07-01","importer_version":"2.1.3","text_redistributed":false}},{"id":2573,"title":"Functional connectivity measures after psilocybin inform a novel hypothesis of early psychosis.","authors":"Carhart-Harris RL, Leech R, Erritzoe D, Williams TM, Stone JM, Evans J, Sharp DJ, Feilding A, Wise RG, Nutt DJ","journal":"Schizophrenia bulletin","publication_date":"2013-11-01","publication_year":2013,"doi":"10.1093/schbul/sbs117","pubmed_id":"23044373","openalex_id":"https://openalex.org/W2122335802","source_url":"https://pubmed.ncbi.nlm.nih.gov/23044373/","substance_tags":"psilocybin","topic_tags":"Brain Imaging,Receptor Pharmacology,Default Mode Network,Consciousness,Aging,Healthy Volunteers,Safety","study_type":"Other","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:54:14","last_checked":"2026-08-09 08:28:28","bibtex":null,"source_record_id":"PMID:23044373","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/23044373/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:23044373","source_url":"https://pubmed.ncbi.nlm.nih.gov/23044373/","doi":"10.1093/schbul/sbs117","pmid":"23044373","publication_date":"2013-11-01","importer_version":"2.1.3","text_redistributed":false}},{"id":2511,"title":"Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study.","authors":"Carhart-Harris RL, Bolstridge M, Rucker J, Day CM, Erritzoe D, Kaelen M, Bloomfield M, Rickard JA, Forbes B, Feilding A, Taylor D, Pilling S, Curran VH, Nutt DJ","journal":"The lancet. Psychiatry","publication_date":"2016-07-01","publication_year":2016,"doi":"10.1016/s2215-0366(16)30065-7","pubmed_id":"27210031","openalex_id":"https://openalex.org/W2396675581","source_url":"https://pubmed.ncbi.nlm.nih.gov/27210031/","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,Addiction,OCD,End-of-Life Distress,Headache / Migraine,Receptor Pharmacology,Randomized Controlled Trial,Treatment-Resistant Depression,Safety,Adverse Events","study_type":"Other","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:54:14","last_checked":"2026-08-09 08:28:27","bibtex":null,"source_record_id":"PMID:27210031","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/27210031/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:27210031","source_url":"https://pubmed.ncbi.nlm.nih.gov/27210031/","doi":"10.1016/s2215-0366(16)30065-7","pmid":"27210031","publication_date":"2016-07-01","importer_version":"2.1.3","text_redistributed":false}},{"id":2427,"title":"Psilocybin with psychological support for treatment-resistant depression: six-month follow-up.","authors":"Carhart-Harris RL, Bolstridge M, Day CMJ, Rucker J, Watts R, Erritzoe DE, Kaelen M, Giribaldi B, Bloomfield M, Pilling S, Rickard JA, Forbes B, Feilding A, Taylor D, Curran HV, Nutt DJ","journal":"Psychopharmacology","publication_date":"2018-02-01","publication_year":2018,"doi":"10.1007/s00213-017-4771-x","pubmed_id":"29119217","openalex_id":"https://openalex.org/W2767530231","source_url":"https://pubmed.ncbi.nlm.nih.gov/29119217/","substance_tags":"psilocybin","topic_tags":"Depression,Receptor Pharmacology,Clinical Trial,Observational Study,Treatment-Resistant Depression,Safety","study_type":"Clinical Trial","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:54:14","last_checked":"2026-08-09 08:28:26","bibtex":null,"source_record_id":"PMID:29119217","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/29119217/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:29119217","source_url":"https://pubmed.ncbi.nlm.nih.gov/29119217/","doi":"10.1007/s00213-017-4771-x","pmid":"29119217","publication_date":"2018-02-01","importer_version":"2.1.3","text_redistributed":false}},{"id":2374,"title":"Effects of psilocybin therapy on personality structure.","authors":"Erritzoe D, Roseman L, Nour MM, MacLean K, Kaelen M, Nutt DJ, Carhart-Harris RL","journal":"Acta psychiatrica Scandinavica","publication_date":"2018-11-01","publication_year":2018,"doi":"10.1111/acps.12904","pubmed_id":"29923178","openalex_id":"https://openalex.org/W2807534705","source_url":"https://pubmed.ncbi.nlm.nih.gov/29923178/","substance_tags":"psilocybin","topic_tags":"Depression,Mechanism of Action,Consciousness,Personality Change,Treatment-Resistant Depression","study_type":"Other","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:54:14","last_checked":"2026-08-09 08:28:25","bibtex":null,"source_record_id":"PMID:29923178","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/29923178/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:29923178","source_url":"https://pubmed.ncbi.nlm.nih.gov/29923178/","doi":"10.1111/acps.12904","pmid":"29923178","publication_date":"2018-11-01","importer_version":"2.1.3","text_redistributed":false}}],"total":57,"page":1,"per_page":20,"pages":3,"resource":"papers","filters":{"q":null,"author":"David Erritzøe","substances":["psilocybin","psilocin"],"topic":null,"study_type":null,"cited_doi":null,"sources":[],"publication_statuses":[],"year":null,"journal":null,"from":null,"to":null,"added_from":null,"added_to":null,"sort":"newly_added","page":1,"per_page":"20"}}